Avadel Pharmaceuticals PLC Stock Ownership - Who owns Avadel Pharmaceuticals?

Insider buying vs selling

Have Avadel Pharmaceuticals PLC insiders been buying or selling?
Thomas S. McHughChief Financial Officer2024-01-162,000$14.50
Mark Anthony McCamishDirector2023-12-2875,000$14.53
Thomas S. McHughChief Financial Officer2023-08-142,000$14.45
Mark Anthony McCamishDirector2023-08-1128,975$14.93
Gregory J. DivisChief Executive Officer2023-08-1010,000$13.20
Geoffrey Michael GlassDirector2023-08-1014,000$13.40

1 of 1

AVDL insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when AVDL insiders and whales buy or sell their stock.

AVDL Shareholders

What type of owners hold Avadel Pharmaceuticals PLC stock?
Janus Henderson Group PLC13.44%12,915,160$202.64MInstitution
Rtw Investments LP9.15%8,798,558$138.05MInstitution
Polar Capital Holdings PLC7.03%6,753,672$105.97MInstitution
Gendell Jeffrey L5.94%5,708,118$89.56MInstitution
Broadfin Healthcare Master Fund Ltd4.30%4,133,464$64.85MInsider
Vivo Capital LLC4.13%3,972,099$62.32MInstitution
James E. Flynn3.82%3,674,506$57.65MInsider
Kevin Kotler3.26%3,130,573$49.12MInsider
Braidwell LP2.78%2,668,549$41.87MInstitution
Wealth Effects LLC2.36%2,264,226$35.53MInstitution

1 of 3

AVDL vs Pharmaceutical Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
AVDL72.86%13.53%Net Selling
DVAX72.83%27.17%Net SellingNet Buying
SUPN45.07%54.93%Net SellingNet Buying

Avadel Pharmaceuticals Stock Ownership FAQ

Who owns Avadel Pharmaceuticals?

Avadel Pharmaceuticals (NASDAQ: AVDL) is owned by 72.86% institutional shareholders, 13.53% Avadel Pharmaceuticals insiders, and 13.61% retail investors. Broadfin Healthcare Master Fund Ltd is the largest individual Avadel Pharmaceuticals shareholder, owning 4.13M shares representing 4.30% of the company. Broadfin Healthcare Master Fund Ltd's Avadel Pharmaceuticals shares are currently valued at $64.48M.

If you're new to stock investing, here's how to buy Avadel Pharmaceuticals stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.